Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism CYP51A1 inhibitors(Cytochrome P450 51 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC20H16Cl3N3O4S |
InChIKeyHAAITRDZHUANGT-FYZYNONXSA-N |
CAS Registry583057-49-2 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Candidiasis, Vulvovaginal | Phase 2 | Spain | 01 Jun 2010 |
Phase 2 | 229 | (Placebo) | gingkzojwd = xyciecbwxv ogkhezieds (qmqbnmzbyi, tfrbkfdghz - yqcmbkcytq) View more | - | 09 Oct 2013 | ||
placebo+arasertaconazole nitrate (Arasertaconazole Nitrate 150 mg) | gingkzojwd = gxeqiofmmh ogkhezieds (qmqbnmzbyi, xzpphsfjao - ngkqllxvyv) View more |





